Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM conditioning before autologous stem cell transplantation for lymphoma
MOH_2017-11-19_001961Phase 2Not yet recruiting
- Sponsor
- Sheba Medical Center
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thiotepa in lymphoma, Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), sponsored by Sheba Medical Center. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
thiotepa
03
Conditions
lymphomaHodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on MOH_2017-11-19_001961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-11-19_001961.